| Entry |
|
| Symbol |
CFB
|
| Name |
|
| Pathway |
| map04610 | Complement and coagulation cascades |
| map05150 | Staphylococcus aureus infection |
|
| Disease |
| H00104 | Alternative complement pathway component defects |
| H00821 | Age-related macular degeneration |
| H01434 | Atypical hemolytic uremic syndrome |
|
| Brite |
KEGG Orthology (KO) [BR:ko00001]
09150 Organismal Systems
09151 Immune system
04610 Complement and coagulation cascades
K01335 CFB; complement factor B
09160 Human Diseases
09172 Infectious disease: viral
05171 Coronavirus disease - COVID-19
K01335 CFB; complement factor B
09171 Infectious disease: bacterial
05150 Staphylococcus aureus infection
K01335 CFB; complement factor B
09180 Brite Hierarchies
09181 Protein families: metabolism
01002 Peptidases and inhibitors
K01335 CFB; complement factor B
Enzymes [BR:ko01000]
3. Hydrolases
3.4 Acting on peptide bonds (peptidases)
3.4.21 Serine endopeptidases
3.4.21.47 alternative-complement-pathway C3/C5 convertase
K01335 CFB; complement factor B
Peptidases and inhibitors [BR:ko01002]
Serine peptidases
Family S1: chymotrypsin family
K01335 CFB; complement factor B
|
| Genes |
» show all
|
| Reference |
|
| Authors |
Sim RB, Tsiftsoglou SA |
| Title |
Proteases of the complement system. |
| Journal |
|
| Reference |
|
| Authors |
Davrinche C, Abbal M, Clerc A |
| Title |
Molecular characterization of human complement factor B subtypes. |
| Journal |
|
| Sequence |
|
| LinkDB |
|